Error loading player: No playable sources found
2025
AGA Epigenetic Mechanisms Driving GI Cancer
Date
May 6, 2023
Explore related products in the following collection:
Society: AGA
The epigenome is the heritable portion of the genome that is mediated by chemical modification of DNA (methylation) or nuclear proteins (histones, transcription factors) without changing the DNA sequence. This session will focus on what defines the epigenome, technologies that allow us to track the epigenome and how novel cancer therapies are developed that target regulators of the epigenome.
The epigenome is the heritable portion of the genome that is mediated by chemical modification of DNA (methylation) or nuclear proteins (histones, transcription factors) without changing the DNA sequence. This session will focus on what defines the epigenome, technologies that allow us to track the epigenome and how novel cancer therapies are developed that target regulators of the epigenome.
Moderators
University of Michigan
Beckman Research Institute, City of Hope Comprehensive Cancer Center
General
Tracks
Related Products
AGA Irritable Bowel Syndrome: Pathophysiology
SOCIETY: AGA
AGA Pediatric Organoid Models of GI Disorders
This session will provide the latest developmental research in human-derived organoids…
AGA Signaling Through the ENS in GI Diseases
SOCIETY: AGA
